Beachbody Company, Inc.
For the period ended Jun 30, 2026. Filed Aug 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Unaudited Condensed Consolidated Financial Statements
Note 1. Description of Business and Summary of Significant Accounting Policies
Business
The Beachbody Company, Inc. (“BODi” or the “Company”) is the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out. The Company is the creator of some of the world’s most popular fitness programs. The Company’s fitness programs are available for streaming through subscription and/or digital program purchases on the Beachbody On Demand Interactive ("BODi") digital platform, accessible through a web browser, iOS devices, Android Devices, and Roku. BODi offers nutritional products such as Shakeology nutrition shakes and Beachbody Performance supplements, which have been designed and clinically tested to help customers achieve their goals. The Company’s revenue has historically been generated primarily through a network of micro-influencers (“Partners”), social media marketing channels, and direct response advertising. On September 30, 2024, the Company announced strategic initiatives to transition its network business from a Multi-Level Marketing ("MLM") model with its Partners to a single level affiliate model (the "Pivot").
Basis of Presentation and Principles of Consolidation
The Company prepares its unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”), and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”).
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that may affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Significant estimates in our condensed consolidated financial statements include, but are not limited to, the useful life and recoverability of long-lived assets, the valuation of warrant liabilities, the recognition and measurement of income tax assets and liabilities, the impairment of goodwill, and the net realizable value of inventory. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities. Actual results could differ from those estimates. We periodically review estimates and assumptions and we reflect the effects of changes, if any, in the unaudited condensed consolidated financial statements in the period that they are determined.
The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and, in the opinion of management, include all normal recurring adjustments necessary for the fair statement of the Company’s financial position, results of operations, and cash flows. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated in consolidation. The financial data and other financial information disclosed in the notes to these unaudited condensed consolidated financial statements are also unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. Interim results are not necessarily indicative of the results that may be expected for the full fiscal year or any other period.
Summary of Changes in Significant Accounting Estimates
Recently Adopted Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, to improve disclosures about a company's income taxes paid and the effective rate reconciliation table. The Company adopted this new accounting guidance on a retrospective basis on January 1, 2025, and the adoption didnot have a material effect on its unaudited condensed consolidated financial statements.
In July 2025, the FASB issued ASU 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets, which amends ASC 326-20 to provide a practical expedient and an accounting policy election (for all entities other than public business entities that elect the practical expedient) related to the estimation of expected credit losses for current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606. The Company adopted this new accounting guidance on January 1, 2026, and the adoption didnot have a material effect on its unaudited condensed consolidated financial statements.
Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, to provide additional disclosure about the nature of a company's expenses included in the income statement. The guidance in this update will be effective for public companies for annual periods beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. The Company is evaluating the potential impact of adopting this guidance on its unaudited condensed consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, Targeted Improvement to the Accounting for Internal-Use Software, which amends certain aspects of the accounting for and disclosure of software costs under ASC 350-40. The amendments also supersede the guidance on web site development costs in ASC 350-50. The guidance in this update will be effective for all entities for annual periods beginning after December 15, 2027 and interim reporting periods within those reporting periods. The Company is evaluating the potential impact of adopting this guidance on its unaudited condensed consolidated financial statements.
In December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which is intended to improve the navigability of the guidance in ASC 270 and clarify when it applies. The guidance is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is evaluating the potential impact, if any, of adopting this guidance on its unaudited condensed consolidated financial statements.
Note 2. Revenue
The Company’s revenue disaggregated by geographic region is as follows (in thousands):
| Three months ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Geographic region: | ||
| United States | $46,055 | $58,997 |
| Rest of world1 | 3,558 | 4,944 |
| Total revenue | $49,613 | $63,941 |
| Six months ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Geographic region: | ||
| United States | $96,169 | $125,849 |
| Rest of world1 | 7,728 | 10,455 |
| Total revenue | $103,897 | $136,304 |
(1)Consists of Canada, United Kingdom, and France. Other than the United States, no single country accounted for more than 10% of total revenue during the three and six months ended June 30, 2026 and 2025.
The Company determined that, in addition to the preceding table, the disaggregation of revenue by revenue type as presented in the unaudited condensed consolidated statements of operations achieves the disclosure requirement to disaggregate revenue into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors.
Deferred Revenue
Deferred revenue is recorded for nonrefundable cash payments received for the Company’s performance obligation to transfer, or stand ready to transfer, goods or services in the future. Deferred revenue consists of subscription fees billed that have not been recognized and physical products sold that have not yet been delivered. The Company expects to recognize approximately 99% of the remaining performance obligations as revenue in the next 12 months, and the remainder thereafter. During the three andsix months ended June 30, 2026, the Company recognized$16.3 million and$43.1 million, respectively, of revenue that was included in the deferred revenue balance as of December 31, 2025. During the three and six months ended June 30, 2025, the Company recognized$21.5 million and$57.8 million, respectively, of revenue that was included in the deferred revenue balance as of December 31, 2024.
Note 3. Fair Value Measurements
The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):
| Level 1 | Level 2 | Level 3 | |
|---|---|---|---|
| Assets | |||
| Restricted short-term investments | $— | $4,250 | $— |
| Total assets | $— | $4,250 | $— |
| Liabilities | |||
| Term Loan Warrants | $— | $— | $699 |
| Common Stock Warrants | — | — | 3,126 |
| Total liabilities | $— | $— | $3,825 |
| Level 1 | Level 2 | Level 3 | |
| Assets | |||
| Restricted short-term investments | $— | $4,250 | $— |
| Total assets | $— | $4,250 | $— |
| Liabilities | |||
| Term Loan Warrants | $— | $— | $733 |
| Common Stock Warrants | — | — | 3,420 |
| Total liabilities | $— | $— | $4,153 |
Fair values of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, and other current liabilities approximate their recorded value due to the short period of time to maturity. Restricted short-term investments of $4.3 million at June 30, 2026 consist of aone-year certificate of deposit (“CD”) that matured on July 26, 2026 with an interest rate of 3.5%, which is restricted due to a contractual agreement. Upon the maturity of this CD on July 26, 2026, the Company entered into a $1.75 million 90 day CD at an interest rate of 3.0%. The remaining cash balance of $2.5 million will be available for general corporate purposes of the Company. The Company’s Term Loan Warrants (as defined below) and Common Stock Warrants (as defined below) are classified within Level 3 of the fair value hierarchy because their fair values are based on significant inputs that are unobservable in the market.
Private Placement Warrants
The Company's outstanding warrants for the purchase of 106,667 shares of the Company's Class A common stock at an exercise price of $575.00 per share (the "Private Placement Warrants") expired unexercised on June 25, 2026. These warrants had no outstanding warrant liability at the time of their expiration.
Public Warrants
The Company's outstanding warrants for the purchase of 200,000 shares of the Company's Class A common stock at an exercise price of $575.00 per share (the "Public Warrants") expired unexercised on June 25, 2026. These warrants had no outstanding warrant liability at the time of their expiration.
Term Loan Warrants
The Company determined the fair value of the Term Loan Warrants (as defined below) using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A common stock. Volatility was based on the implied volatility derived from the Company's historical volatility. The expected life was based on the remaining contractual term of the Term Loan Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Term Loan Warrants expected life. The significant unobservable input used in the fair value measurement of the Term Loan Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. See Note 9, Debt, for additional information regarding the Term Loan Warrants.
The following table presents significant assumptions utilized in the valuation of the Term Loan Warrants at June 30, 2026 and December 31, 2025:
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Risk-free rate | 4.1% | 3.6% |
| Dividend yield rate | — | — |
| Volatility | 91.6% | 91.1% |
| Contractual term (in years) | 3.11 | 3.60 |
| Exercise price | $6.26 | $6.26 |
The following table presents changes in the fair value of the Term Loan Warrants for the three andsix months ended June 30, 2026 and 2025 (in thousands):
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Balance, beginning of period | $767 | $504 | $733 | $390 |
| Change in fair value | (68) | (265) | (34) | (151) |
| Balance, end of period | $699 | $239 | $699 | $239 |
For the three and six months ended June 30, 2026 and 2025, the change in the fair value of the Term Loan Warrants was due to the change in price of the Company's Class A Common Stock, the remaining contractual term and the risk-free rate. The changes in fair value are included in the unaudited condensed consolidated statements of operations as a component of change in fair value of warrant liabilities and in the unaudited condensed consolidated balance sheets as other liabilities.
Common Stock Warrants
The Company issued warrants (the "Common Stock Warrants") on December 10, 2023, to certain institutional investors to purchase 543,590 shares of Class A common stock at an exercise price of $11.24 per share. The Common Stock Warrants may be exercised at any time beginning June 13, 2024, and will expire on June 13, 2029. The Company determined the fair value of the Common Stock Warrants using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A common stock. Volatility was based on the implied volatility derived from the Company's historical volatility. The expected life was based on the remaining contractual term of the Common Stock Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Common Stock Warrants expected life. The significant unobservable input used in the fair value measurement of the Common Stock Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively.
The following table presents significant assumptions utilized in the valuation of the Common Stock Warrants on June 30, 2026 and December 31, 2025:
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Risk-free rate | 4.1% | 3.6% |
| Dividend yield rate | — | — |
| Volatility | 89.3% | 90.4% |
| Contractual term (in years) | 2.95 | 3.45 |
| Exercise price | $11.24 | $11.24 |
The following table presents changes in the fair value of the Common Stock Warrants for the three andsix months ended June 30, 2026 and 2025 (in thousands):
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Balance, beginning of period | $3,577 | $2,358 | $3,420 | $1,783 |
| Change in fair value | (451) | (1,293) | (294) | (718) |
| Balance, end of period | $3,126 | $1,065 | $3,126 | $1,065 |
For the three and six months ended June 30, 2026 and 2025, the change in the fair value of the Common Stock Warrants resulted from the change in price of the Company’s Class A common stock, remaining contractual term, and the risk-free rate. The changes in fair value are included in the unaudited condensed consolidated statements of operations as a component of change in fair value of warrant liabilities and in the unaudited condensed consolidated balance sheets as other liabilities.
Note 4. Inventory
Inventory, net consists of the following (in thousands):
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Raw materials and work in process | $5,888 | $5,194 |
| Finished goods | 6,682 | 4,216 |
| Total inventory | $12,570 | $9,410 |
Total adjustments to the carrying value of excess inventory and inventory on hand to net realizable value were$0.2 million and$0.8 million during the three and six months ended June 30, 2026, respectively, and$0.4 million and$0.6 million during the three and six months ended June 30, 2025, respectively. The Company recorded all of these adjustments in nutrition and other cost of revenue for the three and six months ended June 30, 2026 and 2025, respectively.
Note 5. Other Current Assets
Other current assets consist of the following (in thousands):
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Accounts receivable, net | $1,346 | $1,138 |
| Deferred Affiliate costs | 450 | 645 |
| Deferred Partner costs | 376 | 1,371 |
| Other | 1,030 | 1,184 |
| Total other current assets | $3,202 | $4,338 |
Note 6. Property and Equipment, Net
Property and equipment, net consists of the following (in thousands):
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Computer software and web development | $102,116 | $107,539 |
| Computer equipment | 9,671 | 12,553 |
| Leasehold improvements | — | 20 |
| Furniture, fixtures and equipment | 310 | 470 |
| Computer software and web development projects in-process | 241 | — |
| Property and equipment, gross | 112,338 | 120,582 |
| Less: Accumulated depreciation | (106,523) | (112,059) |
| Total property and equipment, net | $5,815 | $8,523 |
The Company recorded depreciation expense related to property and equipment in the following expense categories of its unaudited condensed consolidated statements of operations asfollows (in thousands):
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Cost of revenue | $1,132 | $775 | $2,484 | $2,333 |
| Enterprise technology and development | 814 | 1,247 | 1,690 | 2,577 |
| Total depreciation | $1,946 | $2,022 | $4,174 | $4,910 |
Note 7. Accrued Expenses and Other Current Liabilities
Accrued expenses consist of the following (in thousands):
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| Advertising | $3,124 | $3,928 |
| Employee compensation and benefits | 2,876 | 3,796 |
| Inventory, shipping and fulfillment | 1,708 | 2,243 |
| Outside professional services | 1,524 | 2,170 |
| Sales and other taxes | 1,505 | 1,928 |
| Information technology | 1,334 | 1,308 |
| Other accrued expenses | 1,020 | 3,035 |
| Total accrued expenses | $13,091 | $18,408 |
As of December 31, 2025, we reclassified accrued Partner costs to other accrued expenses to conform to the current year presentation. This reclassification had no impact on total accrued expenses.
Advertising costs, which are primarily comprised of social media, television media, and internet advertising expenses and also include print, radio, and infomercial production costs, were$7.8 million and$18.9 million for the three and six months ended June 30, 2026, respectively, and$10.5 million and$22.1 million for the three and six months ended June 30, 2025, respectively.
Other Current Liabilities
On October 1, 2025, the Company entered into a financing agreement with AFCO Acceptance Corporation ("AFCO") to finance certain of its annual insurance premiums. The Company financed $1.7 million, which will be paid over aneleven month period with the first payment due on November 1, 2025. The financing has an interest rate of 6.84% and AFCO has a security interest in the underlying policies that were financed. The $0.5 million and $1.4 million outstanding as of June 30, 2026 and December 31, 2025, respectively, is recorded in other current liabilities and accounts payable in the condensed consolidated balance sheet and the interest expense is recorded in interest expense in the condensed consolidated statement of operations.
On October 1, 2025, the Company entered into a financing agreement with First Insurance Funding ("FIF") to finance certain of its annual insurance premiums. The Company financed $1.6 million, which will be paid over anine month period with the first payment due on November 1, 2025. The financing has an interest rate of 6.82% and FIF has a security interest in the underlying policies that were financed. The $0.2 million and $1.2 million outstanding as of June 30, 2026 and December 31, 2025, respectively, is recorded in other current liabilities and accounts payable in the condensed consolidated balance sheet and the interest expense is recorded in interest expense in the condensed consolidated statement of operations.
Note 8. Commitments and Contingencies
Inventory Purchase and Service Agreements
The Company has noncancelable inventory purchase and service agreements with multiple service providers which expire at varying dates through 2029. During the three and six months ended June 30, 2026 and 2025, there wereno losses on inventory purchase commitments. Service agreement obligations include amounts related to fitness and nutrition trainers, information systems support, and other technology projects.
Future minimum payments under noncancelable service and inventory purchase agreements for the periods succeeding June 30, 2026 are as follows (in thousands):
| Six months ending December 31, 2026 | $12,267 |
|---|---|
| Year ending December 31, 2027 | 2,442 |
| Year ending December 31, 2028 and thereafter | 1,201 |
| $15,910 |
The preceding table excludes royalty payments to fitness trainers, talent, and others that are based on future sales as such amounts cannot be reasonably estimated. During the six months ended June 30, 2026, the Company paid$1.3 million of royalty payments exclusive of guaranteed payments.
Lease Commitments
The Company leases facilities under noncancelable operating leases expiring through 2029. These lease obligations will require payments of approximately$0.5 million during the six months ending December 31, 2026,$0.5 million for the year ending December 31, 2027 and$0.4 million in total thereafter through 2029.
Contingencies
The Company is subject to litigation from time to time in the ordinary course of business. Such claims typically involve its products, intellectual property, and relationships with suppliers, customers, distributors, employees, and others. Contingent liabilities are recorded when it is both probable that a loss has occurred and the amount of the loss can be reasonable estimated. Although it is not possible to predict how litigation and other claims will be resolved, the Company does not believe that any currently identified claims or litigation matters will have a material adverse effect on its condensed consolidated financial position or results of operations.
On May 22, 2023, Jessica Lyons, an individual, and a group of other plaintiffs filed a class action complaint with the Los Angeles County Superior Court alleging that the Company misclassified its Partners as contractors rather than as employees and committed other violations of the California Labor Code. The Company understands that the plaintiffs in this matter intend on filing additional claims under the Private Attorney General Act of 2004 ("PAGA"). The Company and certain executive officers are listed as defendants in the complaint. The plaintiffs are seeking monetary damages. The Company filed a motion to compel arbitration in the case. The firm representing Ms. Lyons has also filed 28 arbitration actions in Los Angeles County in anticipation that the Company's motion to compel arbitration will be upheld. We have continued to deny the allegations in the complaint and have vigorously defended ourselves in this action. As of October 7, 2025, the parties reached a settlement that resulted in a dismissal of all claims, including all 28 filed arbitrations. A motion to dismiss the entire class action and PAGA complaint was filed on December 29, 2025, which was granted on January 12, 2026, and has now been formally dismissed in its entirety.
On June 14, 2024, Bryan Reilly on behalf of himself and similarly situated current and former stockholders of Forest Road Acquisition Corp., which later became the Beachbody Company, Inc. (“Forest Road”), filed a verified class action complaint (the “Reilly Action”) in the Delaware Chancery Court against the former directors and officers of Forest Road, as well as Forest Road Acquisition Sponsor LLC, Forest Road Company LLC, Zach Tarica, and Jeremy Tarica (together the “Forest Road Sponsor Defendants”) alleging claims for breach of fiduciary duty in connection with the merger among Forest Road, The Beachbody Company, Inc., and Myx in 2021 (the “Merger”). The lawsuit also brought claims against the Company, Kevin Meyer, and The Raine Group LLC (“Raine”) alleging aiding and abetting breach of fiduciary duty, and against the former Forest Road directors and officers, the Forest Road Sponsor Defendants, Raine, and Meyer for unjust enrichment. We also have certain indemnification obligations as to some or all of the former Forest Road directors and Raine as to certain claims.
The Reilly Action generally alleges that the proxy that Forest Road issued prior to the Merger contained numerous material misstatements and omissions that impaired the Forest Road stockholders’ ability to make an informed decision regarding whether to redeem their stock in connection with the Merger. The plaintiff also asserts that the Merger was a conflicted transaction because the Forest Road Sponsor Defendants and the former Forest Road directors were incentivized to close the Merger even if it was a value-decreasing transaction for Forest Road’s public stockholders. As to the Company, Meyer, and Raine, the complaint alleges that these defendants aided and abetted the Forest Road defendants’ disclosure violations. On December 5, 2024, the plaintiffs in the Reilly Action dismissed without prejudice the aiding and abetting claims against the Company and Raine. Consequently, the Company is not currently a party to the litigation but its indemnification obligation as to certain of the remaining defendant directors remains.
On July 1, 2025, the Defendants in the Reilly Action filed a motion to dismiss with the Delaware Chancery Court. On September 30, 2025, this motion to dismiss was granted, dismissing the action with prejudice and giving the Plaintiffs thirty days to file an appeal. On October 15, 2025, Plaintiffs filed a notice of appeal for the Reilly Action. The appeal was heard on April 22, 2026, and on May 7, 2026, the Supreme Court of the State of Delaware issued its order, affirming the lower court’s decision and dismissing the case.
On October 14, 2024, the firm Milberg Coleman Bryson Phillips Grossman ("Milberg") filed 10 arbitration demands alleging that the Company violated the Video Privacy Protection Act. The arbitration demands state that Milberg currently represents approximately 6,239 additional subscribers of BODi and intends to file similar demands for each person. The plaintiffs are seeking monetary damages as well as injunctive and equitable relief. As of September 11, 2025, the parties reached a settlement that resulted in a release of all threatened claims, including on behalf of all alleged affected subscribers.
The Company disputes the allegations in the above referenced active matters and intends to defend the matters vigorously. Some of our legal proceedings, such as the above referenced complaints, may be based on complex claims involving substantial uncertainties and unascertainable damages. Accordingly, other than the pending and settled matters noted above, it is not possible to determine the probability of loss or estimate damages for any of the above matters, and therefore the Company has not established reserves for any of these proceedings other than the pending and settled matters noted above. When the Company determines that a loss is both probable and reasonably estimable, the Company records a liability, and, if the liability is material, discloses the amount of the liability reserved. Given that such proceedings are subject to uncertainty, there can be no assurance that such legal proceedings, either individually or in the aggregate, will not have a material adverse effect on our business, results of operations, financial condition or cash flows.
Note 9. Debt
ABL Facility
On May 13, 2025, (the “Asset-Based Lending Facility Effective Date”), the Company, the lenders party thereto and Tiger Finance, LLC (“Tiger”), as administrative agent, entered into a $35.0 million asset-based lending facility (the "ABL Facility"), which includes a $10.0 million uncommitted accordion, that matures on May 13, 2028 with the potential for twoone-year extensions which would need to be approved by Tiger (the "Credit Agreement"). The amount that the Company may borrow under the ABL Facility is based on a borrowing base calculated based on advance rates for the various assets serving as collateral for the ABL Facility. The Company borrowed $25.0 million on the Asset-Based Lending Facility Effective Date. In connection with the ABL Facility, the Company incurred $1.8 million of third-party debt issuance costs which were recorded in the unaudited condensed consolidated balance sheet at June 30, 2026 as a reduction of long-term debt and are being amortized over the term of the ABL Facility using the effective-interest method. The ABL Facility bears interest based on the one-month Secured Overnight Financing Rate ("SOFR") plus 9.00% at its inception, which can decrease to the one-month SOFR plus 7.75% after May 13, 2026 if the Company's fixed charge coverage ratio is greater than 1.10 x. The SOFR is subject to a 3.5% floor. The ABL Facility had an effective interest rate of 14.86% and a cash interest rate of 12.66% for the six months ended June 30, 2026. The Company recorded$1.0 million and$2.0 million of interest related to the ABL Facility during the three and six months ended June 30, 2026, respectively. The ABL Facility is secured by a first lien on substantially all of the Company’s assets.
The ABL Facility also contains customary representations, warranties, and covenants, which include, but are not limited to, restrictions on indebtedness, liens, restricted payments, asset sales, affiliate transactions, changes in line of business, investments, negative pledges and amendments to organizational documents and material contracts. The ABL Facility contains customary events of default, which among other things include (subject to certain exceptions and cure periods): (1) failure to pay principal, interest, or any fees or certain other amounts when due; (2) breach of any representation or warranty, covenant, or other agreement in the ABL Facility and other related loan documents; (3) the occurrence of certain bankruptcy or insolvency proceedings; and (4) certain other customary events of default.
The Company’s financial covenants under the ABL Facility were as follows until they were amended as part of the First Amended ABL Facility Credit Agreement (defined below):
The Company shall not fail to exceed the Three Month Total Billings Target (as defined in the Credit Agreement).
The Company shall not fail to exceed the Quarterly Digital Subscriptions Target (as defined in the Credit Agreement).
On an annual basis, the amount of Capital Expenditures (as defined in the Credit Agreement) for the year then ended shall be less than $10 million, which can increase based on certain cost savings metrics.
Liquidity, as defined in the Credit Agreement, shall be greater than $12 million at all times and during a Cure Period (as defined in the Credit Agreement) shall be greater than $13.2 million.
See ABL Facility First Amendment and ABL Facility Second Amendment below for discussion of the amendments to the above financial covenants.
If there is an event of default, including not being in compliance with the financial covenants, the ABL Facility will bear interest from the date of such event of default until the event of default is cured or waived in writing by the Lenders at the post default rate, which is the rate of interest in effect pursuant to the ABL Facility plus 3.50%. In the event of default, the Lenders could also require repayment of the outstanding balance of the ABL Facility. Repayment of the ABL Facility due to an event of default or a voluntary prepayment ofall or a portion of the ABL Facility by the Company would require the Company to pay the prepayment premium of (a) Make Whole (as defined in the Credit Agreement) if repaid in the 18 months after the Asset-Based Lending Facility Effective Date, (b)5.0% if repaid 19-24 months after the Asset-Based Lending Facility Effective Date and (c)2.0% if repaid 25-36 months after the Asset-Based Lending Facility Effective Date.
On January 7, 2026, (the “ABL Facility First Amendment Effective Date”), the Company and Tiger entered into Amendment No. 1 to the Credit Agreement (the "First Amended ABL Facility Credit Agreement") which amended the Company’s existing Credit Agreement. The First Amended ABL Facility Credit Agreement amends, among other things, certain terms of the Credit Agreement including without limitation, to (1) eliminate the capital expenditures covenant, (2) increase the minimum liquidity financial covenant from $12 million to $15 million, (3) the minimum Three Months Total Billings Target and the minimum Monthly Digital Subscriptions financial covenants are not tested unless the Company's cash balance is less than $4.6 million greater than the outstanding debt principal (a Covenant Testing Period, as defined in the First Amended ABL Facility Credit Agreement), (4) decrease the minimum Monthly Digital Subscriptions Target covenant level from 850,000 to 700,000, which is tested if a Covenant Testing Period (as defined in the First Amended ABL Facility Credit Agreement) has been triggered, (5) add an additional financial covenant such that if a Covenant Testing Period (as defined in the First Amended ABL Facility Credit Agreement) is in effect, the Company must maintain a minimum billings fixed charge coverage ratio ("BFCCR") (as defined in the First Amended ABL Facility Credit Agreement) of at least 1.1 x, (6) extended the date for potential decrease in the interest rate of the ABL Facility from SOFR plus 9.00% to SOFR plus 7.75% from May 13, 2026 to December 31, 2026, (7) extended the Make Whole prepayment premium from November 13, 2026 to July 7, 2027, and (8) amend certain financial definitions, reporting covenants and other covenants thereunder.
The Company incurred a 1% amendment fee on the outstanding ABL Facility balance prior to the amendment (fee of $0.3 million) which was recorded as of the ABL Facility First Amendment Effective Date in the consolidated balance sheet as a reduction of long-term debt and is being amortized over the remaining term of the ABL Facility using the effective-interest method.
On August 3, 2026, (the “ABL Facility Second Amendment Effective Date”), the Company and Tiger entered into Amendment No. 2 to the Credit Agreement (the "Second Amended ABL Facility Credit Agreement") which amended the Company’s existing Credit Agreement which had been previously amended by the ABL Facility First Amendment on January 7, 2026. The Second Amended ABL Facility Credit Agreement amends, among other things, certain terms of the Credit Agreement including without limitation, to (1) the minimum Three Months Total Billings Target and the minimum Monthly Digital Subscriptions financial covenants are not tested unless the Company's cash balance is less than $22.5 million, (a Covenant Testing Period, as defined in the Second Amended ABL Facility Credit Agreement), a decrease from the previous required cash level of $4.6 million greater than the outstanding debt principal ($29.6 million at June 30, 2026), (2) eliminate the minimum BFCCR covenant, (3) increase the minimum liquidity financial covenant from $15 million to $18 million, which will decrease at a monthly amount of approximately $0.2 million beginning March 1, 2027, to $16 million, (4) decrease the minimum Monthly Digital Subscriptions Target covenant level from 700,000 to 650,000 through December 31, 2026 and 550,000 thereafter, which is tested if a Covenant Testing Period (as defined in the Second Amended ABL Facility Credit Agreement) has been triggered, (5) the Three Months Billings Target (as defined in the Second Amended ABL Facility Credit Agreement) increased from 90% to 92.5% of the forecast provided to the lender on the ABL Facility Second Amendment Effective Date, which is tested if a Covenant Testing Period (as defined in the Second Amended ABL Facility Credit Agreement) has been triggered, (6) the interest rate of the ABL Facility will remain at SOFR plus 9.00% till the maturity of the ABL Facility, (7) the monthly principal payment will increase by approximately $0.1 million, and (8) amend certain financial definitions, reporting covenants and other covenants thereunder.
The Company incurred an amendment fee of $0.3 million which was recorded as of the ABL Facility Second Amendment Effective Date in the consolidated balance sheet as a reduction of long-term debt and is being amortized over the remaining term of the ABL Facility using the effective-interest method.
See Note 16, Subsequent Events, for additional information on the Second Amended ABL Facility Credit Agreement, including amendments to the financial covenants.
Principal Balance-ABL Facility
As of June 30, 2026, the principal balance outstanding under the ABL Facility was $25.0 million. The aggregate amounts of payments due for theperiods succeeding June 30, 2026 and reconciliation of the Company’s debt balances, net of debt discount and debt issuance costs, are as follows (in thousands):
| Six months ending December 31, 2026 | $1,062 |
|---|---|
| Year ending December 31, 2027 | 2,125 |
| Year ending December 31, 2028 | 21,813 |
| Total debt | 25,000 |
| Less current portion | (2,125) |
| Less unamortized debt discount and debt issuance costs | (1,435) |
| Total long-term debt | $21,440 |
The ABL Facility has no required payment of principal until July 1, 2026 and thereafter the principal payments are approximately $2.1 million per year, which is split into equal monthly payments of $177,083. The remaining unpaid principal balance of the ABL Facility will be due on the maturity date of May 13, 2028, unless extended pursuant to its terms.
Repayment of Term Loan
The Company used the proceeds from the ABL Facility to repay in full its Term Loan (as defined below) on May 13, 2025 (outstanding principal balance of $17.3 million as of the date of repayment) along with the repayment of the outstanding paid in kind of $0.5 million, a prepayment premium of $0.3 million and outstanding accrued interest of $0.2 million. The repayment of the Term Loan was accounted for as a debt extinguishment and the Company wrote off the remaining amount of unamortized debt discount and debt issuance costs as of the repayment date ($1.7 million) which in addition to the prepayment premium ($0.3 million) and certain legal expenses, was recorded as a loss on debt extinguishment of $2.2 million in the three and six months ended June 30, 2025.
Term Loan
On August 8, 2022 (the “Effective Date”), the Company, Beachbody, LLC as borrower (a wholly owned subsidiary of the Company), and certain other subsidiaries of the Company as guarantors (the “Guarantors”), the lenders (the “Lenders”), and Blue Torch Finance, LLC, ("Blue Torch") as administrative agent and collateral agent for such lenders (the “Term Loan Agent”) entered into a financing agreement which was subsequently amended (collectively with any amendments thereto, the “Financing Agreement”). The Financing Agreement provided for senior secured term loans on the Effective Date in an aggregate principal amount of $50.0 million (the “Term Loan”) which was drawn on the Effective Date. Borrowings under the Term Loan were unconditionally guaranteed by the Guarantors. Such security interest consisted of a first-priority perfected lien on substantially all property and assets of the Company and subsidiaries, including stock pledges on the capital stock of the Company’s material and direct subsidiaries, subject to customary carveouts. In connection with the Financing Agreement, the Company incurred$4.5 million of third-party debt issuance costs which were recorded in the unaudited condensed consolidated balance sheets as a reduction of long-term debt and were amortized over the term of the Term Loan using the effective-interest method.
The Term Loan bore interest at a rate per annum equal to the sum of an applicable margin of 7.15% and the SOFR (based upon an interest period of three months). In addition, the Term Loan borrowings bore additional interest at 3.00% per annum, paid in kind by capitalizing such interest and adding such capitalized interest to the outstanding principal amount of the Term Loan on each anniversary of the Effective Date. The Term Loan had an effective interest rate of 28.00% and a cash interest rate of 11.63% for the period from January 1, 2025 to May 13, 2025 (the date that the Company repaid the Term Loan in full). The Company recorded $0.6 million and $2.1 million of interest related to the Term Loan during the three and six months ended June 30, 2025, respectively.
In connection with the Term Loan, the Company issued to certain holders affiliated with Blue Torch warrants for the purchase of 94,335 shares of the Company’s Class A common stock at an exercise price of $92.50 per share (the "Term Loan Warrants"). The Term Loan Warrants vest on a monthly basis over four years, with 30%,30%,20% and 20% vesting in the first, second, third and fourth years, respectively. The Term Loan Warrants have aseven-year term from the Effective Date. See Note 3, Fair Value Measurements, for information on the valuation of the Term Loan Warrants. The Term Loan Warrants were recorded in the unaudited condensed consolidated balance sheets as warrant liabilities. The initial fair value of the Term Loan Warrants, of $5.2 million, was being amortized as a debt discount over the term of the Term Loan using theeffective-interest method. As noted above, when the Company repaid in full the Term Loan it wrote off the remaining unamortized debt discount. In connection with the Second Amendment, the Company also amended and restated the Term Loan Warrants (the "Warrant First Amendment"). The amendment of the Term Loan Warrants amended the exercise price of the Term Loan Warrants from $92.50 per share to $20.50 per share. The amended exercise price increased the fair value of the Term Loan Warrants as of the Second Amendment Effective Date by $0.8 million and was recorded as of the Second Amendment Effective Date as an incremental debt discount, and in addition to the remaining debt discount was being amortized over the amended term of the Term Loan using the effective-interest method. In connection with the Equity Offering (as defined below), the Term Loan Warrants conversion ratio was amended resulting in an increase in the number of shares purchased upon the exercise of the Term Loan Warrants to 97,482 sharesof the Company's Class A common stock. In connection with the Fifth Amendment, the Company also amended and restated the Term Loan Warrants (the "Warrant Second Amendment"). The Warrant Second Amendment amended the exercise price of the Term Loan Warrants from $20.50 per share to $9.16 per share. The amended exercise price increased the fair value of the Term Loan Warrants as of the Fifth Amendment Effective Date by $0.1 million and was recorded as of the Fifth Amendment Effective Date as an incremental debt discount, and in addition to the remaining debt discount was being amortized over the amended term of the Term Loan using the effective interest method. In connection with the Term Loan Sixth Amendment, the Company also amended and restated the Term Loan Warrants for the purchase of 97,482 shares of the Company’s Class A common stock. The amendment of the Term Loan Warrants amended the exercise price from $9.16 per share to $6.26 per share.
Letter of credit
At June 30, 2026 and December 31, 2025, the Company had one irrevocable standby letter of credit outstanding, totaling $0.1 million which is collateralized by $0.1 million of cash. This letter of credit expires on December 6, 2026 and is automatically extended for one-year terms unless notice of non-renewal is provided 60 days prior to the end of the applicable term. At June 30, 2026 and December 31, 2025, the cash collateralizing this letter of credit is classified as current restricted cash in our unaudited condensed consolidated balance sheet.
Note 10. Segment
The Company is the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out. The Company is the creator of some of the world’s most popular fitness programs. The Company's Chief Operating Decision Maker ("CODM") is itschief executive officer ("CEO"). The Company defines its one segment on the basis of the way in which internally reported financial information is regularly reviewed by the CODM to analyze financial performance, make decisions, and allocate resources.
The Company’s CODM assesses the segments performance by using net income (loss). The CODM uses net income (loss) for its segment in the annual budget and forecasting process. The CODM considers budget to actual variances on a quarterly basis for its profit measures when making decisions about the allocation of operating and capital resources to the segment.
The Company recorded depreciation expense related to its property and equipment of $1.9 million and $4.2 million for the three and six months ended June 30,2026, respectively, and $2.0 million and $4.9 million for the three andsix months ended June 30, 2025, respectively. See Note 6, Property and Equipment, Net, for additional information on the Company's depreciation expense. The Company recorded content amortization expense of $1.3 million and $2.7 million for the three and six months ended June 30,2026, respectively, and $2.3 million and $5.0 million for the three andsix months ended June 30, 2025, respectively. The Company recorded interest income, which is recorded in other income, net, in the condensed consolidated statement of operations, of $0.3 million and $0.6 million for the three and six months ended June 30, 2026, respectively, and $0.3 million and $0.5 million for the three andsix months ended June 30, 2025, respectively.
Since the Company has onlyone reporting segment, the presentation of the Company’s segment’s operating results is the same as the Company’s condensed consolidated statements of operations for the three andsix months ended June 30, 2026 and 2025 and the expenses on the condensed consolidated statement of operations are the significant segment expenses (see the Company’s condensed consolidated statement of operations) and its assets and liabilities are the same as the Company’s condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025 (see the Company’s condensed consolidated balance sheets).
Note 11. Stockholders’ Equity
As of June 30, 2026,2,000,000,000 shares, $0.0001 par value per share are authorized, of which,1,600,000,000 shares are designated as Class A common stock,200,000,000 shares are designated as Class X common stock,100,000,000 shares are designated as Class C common stock and 100,000,000 shares are designated as preferred stock.
Holders of each share of each class of Common Stock are entitled to dividends when, as, and if declared by the Company’s Board of Directors, subject to the rights and preferences of any holders of Preferred Stock outstanding at the time. As of June 30, 2026, the Company had not declared any dividends. The holder of each Class A common stock is entitled toone vote, the holder of each share of Class X common stock is entitled toten votes and except as otherwise required by law, the holder of each share of Class C common stock is not entitled to any voting powers.
Accumulated Other Comprehensive Income (Loss)
The following tables summarize changes in accumulated other comprehensive income (loss) by component during the three months ended June 30, 2026 and 2025 (in thousands):
| Balances at March 31, 2025 | $(58) |
|---|---|
| Other comprehensive loss before reclassifications | (6) |
| Balances at June 30, 2025 | $(64) |
| Balances at March 31, 2026 | $(62) |
| Other comprehensive income before reclassifications | 27 |
| Balances at June 30, 2026 | $(35) |
1 Total denotes foreign currency translation adjustments.
The following tables summarize changes in accumulated other comprehensive income (loss) by component during the six months ended June 30, 2026 and 2025 (in thousands):
| Balances at December 31, 2024 | $(49) |
|---|---|
| Other comprehensive loss before reclassifications | (15) |
| Balances at June 30, 2025 | $(64) |
| Balances at December 31, 2025 | $(47) |
| Other comprehensive income before reclassifications | 12 |
| Balances at June 30, 2026 | $(35) |
1 Total denotes foreign currency translation adjustments.
Note 12. Equity-Based Compensation
Equity Compensation Plans
A summary of the option activity under the Company’s equity compensation plans is as follows:
| Time-Vesting Options Outstanding | ||||
|---|---|---|---|---|
| Number of Options | Weighted-Average Exercise Price (per option) | Weighted-Average Remaining Contractual Term (in years) | Aggregate Intrinsic Value (in thousands) | |
| Outstanding at December 31, 2025 | 714,618 | $22.82 | 6.51 | $2,573 |
| Granted | 50,000 | 8.86 | ||
| Exercised | (15,292) | 6.43 | ||
| Forfeited | (12,896) | 6.43 | ||
| Expired | (1,200) | 6.43 | ||
| Outstanding at June 30, 2026 | 735,230 | $22.53 | 6.26 | $2,438 |
| Exercisable at June 30, 2026 | 572,459 | $26.95 | 5.89 | $1,912 |
A summary of restricted stock unit ("RSU") activity is as follows:
| RSUs Outstanding | |||
|---|---|---|---|
| Number of RSUs · Weighted-Average Fair Value (per RSU) | |||
| Outstanding at December 31, 2025 | 517,580 | $ | 9.24 |
| Granted | 542,964 | 10.53 | |
| Vested | (112,366) | 11.69 | |
| Forfeited | (72,684) | 10.19 | |
| Outstanding at June 30, 2026 | 875,494 | $ | 9.64 |
The fair value of RSUs vested during the three and six months ended June 30, 2026 was$0.2 million and$1.3 million, respectively.$0.8 million and$1.9 million was the fair value of RSUs vested during the three and six months ended June 30, 2025, respectively.
On January 1, 2026, the number of shares available for issuance under the 2021 Incentive Award Plan (the “2021 Plan”) increased by 358,986 pursuant to the terms of the 2021 Plan. As of June 30, 2026,1,046,840 shares of Class A common stock were available for issuance under the 2021 Plan.
Vested RSUs included shares of common stock that the Company withheld on behalf of certain employees to satisfy the minimum statutory tax withholding requirements, as defined by the Company. The Company withheld shares of common stock with an aggregate fair value and remitted taxes of$0.4 million during the six months ended June 30, 2026, which were classified as financing cash outflows in the unaudited condensed consolidated statements of cash flows. The Company canceled and returned these shares to the 2021 Plan, which are available under the plan terms for future issuance.
Employee Stock Purchase Plan ("ESPP")
In May 2022, the Company established an ESPP, the terms of which allow for qualified employees to participate in the purchase of designated shares of the Company’s common stock at a price equal to 85% of the lower of the closing price at the beginning or ending of each six-month purchase period.
On January 1, 2026, the number of shares available for issuance under the ESPP increased by 71,797 pursuant to the terms of the ESPP. As of June 30, 2026,248,772 shares of Class A common stock were available for issuance under the ESPP.
During the six months ended June 30, 2026,14,734 shares of the Company’s common stock were issued pursuant to the ESPP at an average price of $6.43 per share.
Stock-based compensation expense associated with the Company’s ESPP is based on fair value estimated on the date of grant using the Black-Scholes option pricing valuation model and the following weighted-average assumptions for grants during thesix months ended June 30, 2026 and 2025:
| Six months ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Risk-free rate | 3.7% | 4.2% |
| Dividend yield rate | — | — |
| Volatility | 88.0% | 68.7% |
| Expected term (in years) | 0.50 | 0.50 |
| Weighted-average grant date fair value | $1.93 | $1.15 |
Equity-Based Compensation Expense
Equity-based compensation expense for the three andsix months ended June 30, 2026 and 2025 was as follows (in thousands):
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Cost of revenue | $122 | $195 | $223 | $396 |
| Selling and marketing | 95 | 235 | 234 | 505 |
| Enterprise technology and development | 84 | 114 | 180 | 275 |
| General and administrative | 984 | 1,471 | 1,766 | 2,565 |
| Total equity-based compensation | $1,285 | $2,015 | $2,403 | $3,741 |
In connection with the restructuring activities that took place during the three and six months ended June 30, 2025, the Company modified certain stock awards of terminated employees (two employees in the three month period ended June 30, 2025 and approximately 10 employees in the three month period ended March 31, 2025). See Note 13, Restructuring, for additional information on the restructuring activities. The modifications in the three and six months ended June 30, 2025 included accelerating the vesting of any options that would have vested within three to six months of the employee's termination date (12 months for former executives of the Company), and all vested options will be available for exercise for a total of six months after the employee's termination date (that is, three months in addition to the standard three months per original agreement). As a result of these modifications, the Company recognized approximately zero and$0.9 million reduction to equity-based compensation expense in the unaudited condensed consolidated statements of operations for the three and six months ended June 30, 2025, respectively.
- Restructuring
On June 26, 2025, the Company executed a post Pivot restructuring (the "Restructuring") which reduced the Company's headcount by approximately 70 employees (approximately 22% of the Company’s workforce on that date) in the third quarter of 2025. The actions associated with the Restructuring resulted in approximately $2.5 million recorded in the Company's unaudited condensed consolidated statement of operations in the three and six months ended June 30, 2025.
In accordance with GAAP, employee termination benefits were recognized at the date employees were notified and post-employment benefits were accrued as the obligation was probable and estimable. Benefits for employees who provided service greater than 60 days from the date of notification were recognized ratably over the service period.
The following tables summarize activity in the Company’s restructuring-related liability during the three and six months ended June 30,2025 (in thousands):
| Balance at | Restructuring | Payments / | Liability at | |
|---|---|---|---|---|
| March 31, 2025 | Charges | Utilizations | June 30, 2025 | |
| Employee-related costs | $10 | $2,492 | $97 | $2,599 |
| Total costs | $10 | $2,492 | $97 | $2,599 |
| Balance at | Restructuring | Payments / | Liability at | |
|---|---|---|---|---|
| December 31, 2024 | Charges | Utilizations | June 30, 2025 | |
| Employee-related costs | $938 | $2,492 | $(831) | $2,599 |
| Total costs | $938 | $2,492 | $(831) | $2,599 |
- Income Taxes
The Company recorded a provision for income taxes of$0.1 million for the three months ended June 30, 2026 and a provision for income taxes of$0.2 million for the six months ended June 30, 2026, respectively, and a provision for income taxes of$0.1 million and
$0.1 million for the three and six months ended June 30, 2025, respectively. The effective tax rate was 7.9% and 3.9% for the three and six months ended June 30, 2026, respectively, and the effective tax rate was(1.7)% and(1.3)% for the three and six months ended June 30, 2025, respectively.
The tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items arising in that quarter. The Company’s effective tax rate differs from the U.S. statutory tax rate in the three and six months ended June 30, 2026 primarily due to changes in valuation allowances on deferred tax assets as it is more likely than not that some or all of the Company’s deferred tax assets will not be realized.
The Company evaluates its tax positions on a quarterly basis and revises its estimate accordingly. There were no material changes to the Company’s uncertain tax positions, interest, or penalties during the three and six months ended June 30, 2026.
- Income (loss) per Share
The Company computes net income (loss) per share using the two-class method required for participating securities. The two-class method requires income available to common shareholders for the period to be allocated between common stock and participating securities based upon their respective right to receive dividends as if all income for the period had been distributed. The Forest Road Earn-Out Shares are deemed participating securities. These participating securities do not contractually require the holders of such shares to participate in the Company's losses.
Basic income (loss) per common share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding for the period, without considering any dilutive items. The Company applied the two-class method in arriving at basic and diluted income (loss) per common share and in determining diluted income (loss) per common share considering the impact of potentially dilutive securities applying the treasury stock method in arriving at the most dilutive result in arriving at diluted income (loss) per common share. In computing the diluted net income per share, net income is adjusted for the change in fair value of warrant liabilities for warrants that are dilutive.
The computation of net income (loss) per share of Class A and Class X common stock is as follows (in thousands, except share and per share information):
| Three months ended June 30, · Six months ended June 30, | |||||
|---|---|---|---|---|---|
| 2026 · 2025 · 2026 · 2025 | |||||
| Numerator: | |||||
| Net income (loss) | $1,384 | $(5,900) | $3,670 | $(11,648) | |
| Less: Income allocated to participating securities under two-class method | 14 | — | 38 | — | |
| Less: Tax impact of adjustment (1) | (1) | — | (1) | ||
| Net income (loss) available to common shareholders - two class method - basic | 1,371 | (5,900) | 3,633 | (11,648) | |
| Diluted net income (loss) per share: | |||||
| Less: Change in fair value on Term Loan Warrants | 68 | — | 34 | — | |
| Less: Change in fair value on Common Stock Warrants | 451 | — | — | — | |
| Less: Tax impact of adjustment (1) | (20) | (1) | |||
| Net income (loss) available to common shareholders - diluted | $872 | $(5,900) | $3,600 | $(11,648) | |
| Denominator: | |||||
| Weighted-average common shares outstanding, basic | 7,182,414 | 6,950,761 | 7,148,294 | 6,917,062 | |
| Dilutive effect of: | |||||
| RSUs | 430,581 | — | 340,542 | — | |
| Options | 235,902 | — | 166,787 | — | |
| Term Loan Warrants | 44,327 | — | 40,587 | — | |
| Common Stock Warrants | 11,379 | — | — | — | |
| Weighted-average common shares outstanding, diluted | 7,904,603 | 6,950,761 | 7,696,210 | 6,917,062 | |
| Net income (loss) per common share, basic | $0.19 | $(0.85) | $0.51 | $(1.68) | |
| Net income (loss) per common share, diluted | $0.11 | $(0.85) | $0.47 | $(1.68) | |
(1) Tax impact calculated using the annual effective tax rate.
Basic net income (loss) per common share is the same as dilutive net income (loss) per common share for the three and six months ended June 30, 2025 as the inclusion of all potential common shares would have been antidilutive in those periods.
The following table presents the common shares as of the end of the respective period that are excluded from the computation of diluted net income (loss) per common share as of the periods presented because including them would have been antidilutive:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Time-vesting options | 499,328 | 860,500 | 568,443 | 860,500 |
| RSUs | 444,913 | 554,766 | 534,952 | 554,766 |
| Compensation warrants | 79,612 | 79,612 | 79,612 | 79,612 |
| Public and Private Placement Warrants | — | 306,667 | — | 306,667 |
| Term Loan Warrants | 53,155 | 97,482 | 56,895 | 97,482 |
| Common Stock Warrants | 532,211 | 543,590 | 543,590 | 543,590 |
| Forest Road Earn-out Shares | 75,000 | 75,000 | 75,000 | 75,000 |
| ESPP | 17,919 | — | 19,180 | — |
| 1,702,138 | 2,517,617 | 1,877,672 | 2,517,617 | |
Note 16. Subsequent Events
As mentioned in Note 9, Debt, on August 3, 2026, the Company and Tiger entered into the Second Amended ABL Facility Credit Agreement which amended the Company’s existing Credit Agreement which had been previously amended by the ABL Facility First Amendment on January 7, 2026. The Second Amended ABL Facility Credit Agreement amends, among other things, certain terms of the Credit Agreement including without limitation, to (1) the minimum Three Months Total Billings Target and the minimum Monthly Digital Subscriptions financial covenants are not tested unless the Company's cash balance is less than $22.5 million, (a Covenant Testing Period, as defined in the Second Amended ABL Facility Credit Agreement), a decrease from the previous required cash level of $4.6 million greater than the outstanding debt principal ($29.6 million at June 30, 2026), (2) eliminate the minimum BFCCR covenant, (3) increase the minimum liquidity financial covenant from $15 million to $18 million, which will decrease at a monthly amount of approximately $0.2 million beginning March 1, 2027, to $16 million, (4) decrease the minimum Monthly Digital Subscriptions Target covenant level from 700,000 to 650,000 through December 31, 2026 and 550,000 thereafter, which is tested if a Covenant Testing Period (as defined in the Second Amended ABL Facility Credit Agreement) has been triggered, (5) the Three Months Billings Target (as defined in the Second Amended ABL Facility Credit Agreement) increased from 90% to 92.5% of the forecast provided to the lender on the ABL Facility Second Amendment Effective Date, which is tested if a Covenant Testing Period (as defined in the Second Amended ABL Facility Credit Agreement) has been triggered, (6) the interest rate of the ABL Facility will remain at SOFR plus 9.00% till the maturity of the ABL Facility, (7) the monthly principal payment will increase by approximately $0.1 million, and (8) amend certain financial definitions, reporting covenants and other covenants thereunder.
The Company incurred an amendment fee of $0.3 million which was recorded as of the ABL Facility Second Amendment Effective Date in the consolidated balance sheet as a reduction of long-term debt and is being amortized over the remaining term of the ABL Facility using the effective-interest method.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.